ClinTex
A new study of stimulants suggests that a rapid decrease in antibody levels does not limit the effectiveness of potential vaccines
While the media have been flooded with reports that the effective COVID-19 vaccine is desperate, two articles recently reviewed support the idea that an ever-increasing vaccination is indeed possible, given the fact that people's anti-virus immunity has been spreading over time.
Two studies have focused on T-cells (which play a central role in the immune response system of the body), their presence in SARS-CoV 2 (a virus that causes the COVID-19 virus) or SARS-CoV (the so-called "original SARS" since 2003 year and is the closest human coronavirus to the current strain), with a control group of people who have had.
The first article, titled" targets of t-cell reactions against coronavirus SARS-CoV-2020 in humans with coronavirus SARS-CoV-2 disease COVID-19 and non-immune specialists, "demonstrated two important discoveries published in may in the Cell journal. First, he showed that the reaction of t-cells to the last coronavirus was less frequent than with atypical pneumonia (atypical pneumonia 2003 year). Secondly, he found that some people who did not have an effect on SARS-CoV or SARS-CoV 2 had new virus recognition cells. According to the authors, an important conclusion here is that even if there are no antibodies to this virus (they are not infected), it can be part of the population that has some protection against the last coronavirus. If this happens, efforts to prevent a pandemic will be continued by achieving herd immunity through vaccination.
"The second article of the" COVID-2 and SARS-CoV-19-specific t-cell immune system in SARS cases", published in July in Nature magazine, confirmed the results of the first article. He showed that t-cell reactions to SARS-CoV-2 react to those same proteins set out in the first article, thus reproducing the results of the first substance in this regard. Secondly, the last article, the first, showed that people who have not been exposed to SARS-CoV or SARS-CoV-2 still have t cells that respond to protein antigens from the last virus. This, once again, confirms the hypothesis that the latter may be part of the population with some protection against the coronavirus.
- ClinTex Website: https://clintex.io//
- ClinTex Medium Page: https://medium.com/@clintexcti
- ClinTex Official Telegram: https://t.me/ClinTexCTi
- ClinTex Official Twitter: https://twitter.com/ClinTexCTi